"AI-Enhanced Sepsis Diagnosis: Advancements in Early Detection and Precision Medicine"

The FDA has authorized Prenosis' AI-powered diagnostic tool, Sepsis ImmunoScore, as the first AI tool capable of diagnosing sepsis, a life-threatening condition. The tool uses 22 parameters to assess a patient's risk of sepsis and is integrated into electronic health records for easy access by clinicians. Prenosis worked with the FDA for 18 months to demonstrate the tool's safety and efficacy and plans to conduct additional studies to demonstrate its accuracy and impact on clinical decision-making.